In an op-ed for The Hindu, Dr. Soumya Swaminathan, Former Chief Scientist of WHO and ex-Director General of ICMR, highlights how India’s Truenat platform has transformed TB care globally. She notes that WHO-endorsed, portable molecular diagnostics like Truenat enable same-day test and treat at the primary care level—an essential shift for timely intervention in low-resource settings. Citing The Lancet study and Molbio’s Kochon Prize recognition, she calls it a global acknowledgment of India’s leadership in affordable, inclusive healthcare innovation.